4jhw
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | ==Crystal Structure of Respiratory Syncytial Virus Fusion Glycoprotein Stabilized in the Prefusion Conformation by Human Antibody D25== | |
- | + | <StructureSection load='4jhw' size='340' side='right' caption='[[4jhw]], [[Resolution|resolution]] 3.60Å' scene=''> | |
- | + | == Structural highlights == | |
+ | <table><tr><td colspan='2'>[[4jhw]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [http://en.wikipedia.org/wiki/Human_respiratory_syncytial_virus_a2 Human respiratory syncytial virus a2]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4JHW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4JHW FirstGlance]. <br> | ||
+ | </td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4jha|4jha]]</td></tr> | ||
+ | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">F, fusion glycoprotein ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=11259 Human respiratory syncytial virus A2])</td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4jhw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4jhw OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4jhw RCSB], [http://www.ebi.ac.uk/pdbsum/4jhw PDBsum]</span></td></tr> | ||
+ | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | The prefusion state of respiratory syncytial virus (RSV) fusion (F) glycoprotein is the target of most RSV-neutralizing activity in human sera, but its metastability has hindered characterization. To overcome this obstacle, we identified prefusion-specific antibodies that were substantially more potent than the prophylactic antibody palivizumab. The cocrystal structure for one of these antibodies, D25, in complex with the F glycoprotein revealed D25 to lock F in its prefusion state by binding to a quaternary epitope at the trimer apex. Electron microscopy showed that two other antibodies, AM22 and 5C4, also bound to the newly identified site of vulnerability, which we named antigenic site O. These studies should enable design of improved vaccine antigens and define new targets for passive prevention of RSV-induced disease. | ||
- | + | Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody.,McLellan JS, Chen M, Leung S, Graepel KW, Du X, Yang Y, Zhou T, Baxa U, Yasuda E, Beaumont T, Kumar A, Modjarrad K, Zheng Z, Zhao M, Xia N, Kwong PD, Graham BS Science. 2013 May 31;340(6136):1113-7. doi: 10.1126/science.1234914. Epub 2013, Apr 25. PMID:23618766<ref>PMID:23618766</ref> | |
- | + | ||
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | + | </div> | |
- | + | == References == | |
- | == | + | <references/> |
- | + | __TOC__ | |
+ | </StructureSection> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Human respiratory syncytial virus a2]] | [[Category: Human respiratory syncytial virus a2]] | ||
- | [[Category: Baxa, U | + | [[Category: Baxa, U]] |
- | [[Category: Beaumont, T | + | [[Category: Beaumont, T]] |
- | [[Category: Chen, M | + | [[Category: Chen, M]] |
- | [[Category: Du, X | + | [[Category: Du, X]] |
- | [[Category: Graepel, K W | + | [[Category: Graepel, K W]] |
- | [[Category: Graham, B S | + | [[Category: Graham, B S]] |
- | [[Category: Kumar, A | + | [[Category: Kumar, A]] |
- | [[Category: Kwong, P D | + | [[Category: Kwong, P D]] |
- | [[Category: Leung, S | + | [[Category: Leung, S]] |
- | [[Category: Mclellan, J S | + | [[Category: Mclellan, J S]] |
- | [[Category: Modjarrad, K | + | [[Category: Modjarrad, K]] |
- | [[Category: Xia, N | + | [[Category: Xia, N]] |
- | [[Category: Yang, Y | + | [[Category: Yang, Y]] |
- | [[Category: Yasuda, E | + | [[Category: Yasuda, E]] |
- | [[Category: Zhao, M | + | [[Category: Zhao, M]] |
- | [[Category: Zheng, Z | + | [[Category: Zheng, Z]] |
- | [[Category: Zhou, T | + | [[Category: Zhou, T]] |
[[Category: Immune system]] | [[Category: Immune system]] | ||
[[Category: Immunoglobulin]] | [[Category: Immunoglobulin]] | ||
[[Category: Membrane fusion]] | [[Category: Membrane fusion]] | ||
[[Category: Type i fusion protein]] | [[Category: Type i fusion protein]] |
Revision as of 12:05, 21 December 2014
Crystal Structure of Respiratory Syncytial Virus Fusion Glycoprotein Stabilized in the Prefusion Conformation by Human Antibody D25
|
Categories: Homo sapiens | Human respiratory syncytial virus a2 | Baxa, U | Beaumont, T | Chen, M | Du, X | Graepel, K W | Graham, B S | Kumar, A | Kwong, P D | Leung, S | Mclellan, J S | Modjarrad, K | Xia, N | Yang, Y | Yasuda, E | Zhao, M | Zheng, Z | Zhou, T | Immune system | Immunoglobulin | Membrane fusion | Type i fusion protein